Design and synthesis of 1,2,4‐triazolo[1,5‐a]pyrimidine derivatives as PDE 4B inhibitors endowed with bronchodilator activity
- 29 July 2019
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 352 (8) , 1900002
Abstract
A series of 1,2,4‐triazolo[1,5‐a]pyrimidine derivatives was designed, synthesized, and screened for their phosphodiesterase (PDE 4B) inhibitory activity and bronchodilation ability. Compound 7e showed 41.80% PDE 4B inhibition at 10 µM. Eight compounds were screened for their bronchodilator activity, where compounds 7f and 7e elicited promising bronchodilator activity with EC50 values of 18.6 and 57.1 µM, respectively, compared to theophylline (EC50 = 425 µM). Molecular docking at the PDE 4B active site revealed a binding mode and docking scores comparable to those of a reference ligand, consistent with their PDE 4B inhibition activity.Keywords
This publication has 22 references indexed in Scilit:
- Design, Synthesis, and Pharmacological Evaluation ofN-Acylhydrazones and Novel Conformationally Constrained Compounds as Selective and Potent Orally Active Phosphodiesterase-4 InhibitorsJournal of Medicinal Chemistry, 2012
- Design and Synthesis of New N-(5-Trifluoromethyl)-1H-1,2,4-triazol-3-yl Benzenesulfonamides as Possible Antimalarial PrototypesMolecules, 2011
- Pyrazolopyridines as potent PDE4B inhibitors: 5-Heterocycle SARBioorganic & Medicinal Chemistry Letters, 2010
- Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase GMolecular Cancer Therapeutics, 2009
- Synthesis and Biological Activities of Schiff Bases of 3‐Amino‐1H‐1,2,4‐triazoleChinese Journal of Chemistry, 2009
- Quinolines as a novel structural class of potent and selective PDE4 inhibitors: Optimisation for oral administrationBioorganic & Medicinal Chemistry Letters, 2009
- Fluorinated 1,2,4‐Triazolo[1,5‐a]pyrimidine‐6‐carboxylic Acid Derivatives as Antimycobacterial AgentsArchiv der Pharmazie, 2009
- Recent Advances on Phosphodiesterase 4 Inhibitors for the Treatment of Asthma and Chronic Obstructive Pulmonary DiseaseJournal of Medicinal Chemistry, 2008
- ADME Evaluation in Drug Discovery. 7. Prediction of Oral Absorption by Correlation and ClassificationJournal of Chemical Information and Modeling, 2006
- 2-(Alkylthio)-1,2,4-triazolo[1,5-a]pyrimidines as adenosine 3',5'-monophosphate phosphodiesterase inhibitors with potential as new cardiovascular agentsJournal of Medicinal Chemistry, 1982